Lazard US Systematic Small Cap Equity Port R6 (DELISTED) (RUSRX:DL)
10.51
+0.02
(+0.19%)
USD |
May 29 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.85% | 46.75M | 1.49% | 111.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 4.487M | 3.44% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Portfolio invests at least 80% primarily in equity securities, principally common stocks, of small capitalization US companies included in the Russell 2000 Index. The Advisor identifies investments with fundamental traits that is believed to be undervalued by the market. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Lazard |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
38
-1.010B
Peer Group Low
1.333B
Peer Group High
1 Year
% Rank:
20
4.487M
-4.007B
Peer Group Low
3.323B
Peer Group High
3 Months
% Rank:
57
-3.094B
Peer Group Low
1.001B
Peer Group High
3 Years
% Rank:
23
-3.620B
Peer Group Low
5.721B
Peer Group High
6 Months
% Rank:
45
-7.000B
Peer Group Low
1.144B
Peer Group High
5 Years
% Rank:
22
-7.950B
Peer Group Low
11.56B
Peer Group High
YTD
% Rank:
50
-5.073B
Peer Group Low
883.30M
Peer Group High
10 Years
% Rank:
28
-10.12B
Peer Group Low
29.81B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 13, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 1.08% |
| Stock | 98.51% |
| Bond | 0.01% |
| Convertible | 0.00% |
| Preferred | 0.01% |
| Other | 0.40% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| ADMA Biologics, Inc. | 1.10% | 19.78 | -2.94% |
|
Fixed Income Clearing Corp Repo
|
1.02% | -- | -- |
| Mueller Industries, Inc. | 0.76% | 113.86 | -0.12% |
| Brady Corp. | 0.74% | 80.45 | -0.01% |
| Adtalem Global Education, Inc. | 0.70% | 92.88 | -0.24% |
| Dolby Laboratories, Inc. | 0.68% | 67.54 | -0.15% |
| Medpace Holdings, Inc. | 0.66% | 557.90 | -1.46% |
| Genpact Ltd. | 0.66% | 47.78 | 0.89% |
| Huron Consulting Group, Inc. | 0.63% | 179.51 | 1.76% |
| Dole Plc | 0.62% | 15.45 | 1.05% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | 48.00% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1.00M None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Portfolio invests at least 80% primarily in equity securities, principally common stocks, of small capitalization US companies included in the Russell 2000 Index. The Advisor identifies investments with fundamental traits that is believed to be undervalued by the market. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Lazard |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-29-25) | 0.59% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 395 |
| Stock | |
| Weighted Average PE Ratio | 22.97 |
| Weighted Average Price to Sales Ratio | 2.962 |
| Weighted Average Price to Book Ratio | 3.881 |
| Weighted Median ROE | 30.64% |
| Weighted Median ROA | 8.35% |
| ROI (TTM) | 27.14% |
| Return on Investment (TTM) | 27.14% |
| Earning Yield | 0.0778 |
| LT Debt / Shareholders Equity | 0.9014 |
| Number of Equity Holdings | 388 |
As of April 30, 2025
Growth Metrics
| EPS Growth (1Y) | 28.76% |
| EPS Growth (3Y) | 13.04% |
| EPS Growth (5Y) | 15.33% |
| Sales Growth (1Y) | 8.43% |
| Sales Growth (3Y) | 10.74% |
| Sales Growth (5Y) | 11.67% |
| Sales per Share Growth (1Y) | 17.72% |
| Sales per Share Growth (3Y) | 12.03% |
| Operating Cash Flow - Growth Rate (3Y) | 22.15% |
As of April 30, 2025
Fund Details
| Key Dates | |
| Inception Date | 2/22/2023 |
| Last Annual Report Date | 12/31/2024 |
| Last Prospectus Date | 5/1/2024 |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:RUSRX:DL", "name") |
| Broad Asset Class: =YCI("M:RUSRX:DL", "broad_asset_class") |
| Broad Category: =YCI("M:RUSRX:DL", "broad_category_group") |
| Prospectus Objective: =YCI("M:RUSRX:DL", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |